Reinhart Partners LLC. Purchases 969,408 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Reinhart Partners LLC. grew its position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 15.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,236,262 shares of the company's stock after purchasing an additional 969,408 shares during the period. AdaptHealth comprises about 2.9% of Reinhart Partners LLC.'s holdings, making the stock its 12th largest position. Reinhart Partners LLC. owned approximately 5.37% of AdaptHealth worth $78,441,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Assetmark Inc. acquired a new position in shares of AdaptHealth during the 4th quarter valued at about $28,000. Blue Trust Inc. boosted its position in AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares during the period. Guggenheim Capital LLC boosted its position in AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares during the period. KLP Kapitalforvaltning AS bought a new stake in AdaptHealth during the fourth quarter worth approximately $169,000. Finally, Humankind Investments LLC boosted its position in AdaptHealth by 18.3% during the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock worth $171,000 after purchasing an additional 2,776 shares during the period. 82.67% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Price Performance

AHCO remained flat at $8.82 during trading on Tuesday. The company's stock had a trading volume of 1,301,500 shares, compared to its average volume of 1,284,922. The company's 50 day moving average price is $8.72 and its 200 day moving average price is $9.55. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.90. The company has a market capitalization of $1.19 billion, a PE ratio of -5.35, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64.

Analyst Ratings Changes

A number of equities analysts have recently commented on AHCO shares. Canaccord Genuity Group lifted their price objective on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Truist Financial cut their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Robert W. Baird boosted their price target on AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. UBS Group decreased their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, February 13th. Finally, Royal Bank of Canada decreased their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research note on Thursday, May 8th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.